RHUMBLINE ADVISERS

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in AQST

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$620,031

+$53,395 QoQ

Shares Held

149,046

+9.2% QoQ

Ownership

0.119%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#52

of 185 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 29% Shared 0% None 71%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. AQST ranks #32 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,437,213	$103,278,126
2	UTHR	UNITED THERAPEUTICS Corp	120,078	$65,061,862
3	NBIX	Neurocrine Biosciences Inc	312,832	$52,724,705
4	VTRS	Viatris Inc	2,872,464	$45,614,728
5	ELAN	Elanco Animal Health Inc	1,264,159	$31,110,952
6	HIMS	Hims & Hers Health, Inc.	633,778	$21,973,083
7	LNTH	Lantheus Holdings, Inc.	197,060	$21,861,836
8	ALKS	Alkermes plc.	387,999	$20,331,147

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$620,031	149,046	+9.2%	Shares	Sole	2026-08-12
2026-03-31	$566,636	136,539	+2.2%	Shares	Sole	2026-05-12
2025-12-31	$862,661	133,539	-0.7%	Shares	Sole	2026-02-13
2025-09-30	$751,687	134,470	-4.5%	Shares	Sole	2025-11-06
2025-06-30	$466,286	140,872	+35.0%	Shares	Sole	2025-08-12
2025-03-31	$302,652	104,363	-2.4%	Shares	Sole	2025-05-29
2024-12-31	$380,766	106,957	+3.1%	Shares	Sole	2025-05-29
2024-09-30	$516,416	103,698	+6.0%	Shares	Sole	2024-11-12
2024-06-30	$254,376	97,837	+420.0%	Shares	Sole	2024-08-01
2021-03-31	$97,838	18,815	-4.7%	Shares	Sole	2021-05-06
2020-12-31	$105,609	19,740	+17.6%	Shares	Sole	2021-02-10
2020-09-30	$81,466	16,780	-1.5%	Shares	Sole	2020-11-12
2020-06-30	$82,814	17,040	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.